 |
| Alexander "Bo" Cumbo |
Stanton PR & Marketing represents the syndicate of high-powered life sciences investors that created AavantiBio, a gene therapy company focused on patients with rare genetic disorders.
Bain Capital Life Sciences, Perceptive Advisors, RA Capital Management and Sarepta Therapeutics put together $107M in Series A financing to launch AavantiBio.
Alexander “Bo” Cumbo, who served as chief commercial officer and executive VP at Sarepta, will helm AavantiBio, which is headquartered in the Boston area.
“Bo Cumbo has built a first-in-class rare disease commercial organization and has made tremendous contributions to Sarepta," said Doug Ingram, CEO. “We look forward to continuing to work with Bo as he builds a strong AavantiBio team and advances therapies to treat FA and other rare diseases.”
Stanton’s Scott Lessne handles AavantiBio.
Prosek Partners represents UK activist investor Palliser Capital, which claims Japan’s Toto Ltd, the country's top toilet bowl maker, ranks as an undervalued AI asset play.
New York’s IGB Group is providing strategic communications services to Zim Integrated Shipping Services, which has 129 vessels, as the Israeli company is acquired by Germany’s Hapag-Lloyd in a deal valued at $4.2B.
Prosek Partners represents Nuveen as it acquires London-based Schroders, which relies on Brunswick Group for PR counsel, in a $13.5B deal.
Qualcomm has recruited Brett Simpson for the senior VP-IR slot at the San Diego-based wireless technology company.
Reevemark handles Eddie Bauer LLC as the retailer inks a Chapter 11 restructuring pact that has it conducting liquidation sales at its US and Canadian stores while working to find a buyer for either all of or part of the chain.
